T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$883M |
| 2 |
AbbVie
ABBV
|
+$660M |
| 3 |
Intuit
INTU
|
+$528M |
| 4 |
Xcel Energy
XEL
|
+$466M |
| 5 |
Exelon
EXC
|
+$430M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$1.2B |
| 2 |
TE Connectivity
TEL
|
+$607M |
| 3 |
Equifax
EFX
|
+$347M |
| 4 |
KLA
KLAC
|
+$317M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.65% |
| 2 | Healthcare | 22.76% |
| 3 | Financials | 12.37% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Industrials | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Lantheus
LNTH
$6.59B
| $88.5M | 0.06% |
1,071,578
+12,013
| +1% | +$775K |
|
277
Mobileye
MBLY
$7.52B
| $88.3M | 0.06% |
2,040,057
-161,950
| -7% | -$6.34M |
|
|
ABCM
278
DELISTED
Abcam PLC
ABCM
| $88.2M | 0.06% |
6,556,002
+465,616
| +8% | +$6.95M |
|
279
Orion
OEC
$365M
| $87.2M | 0.06% |
3,340,741
-304,252
| -8% | -$6.88M |
|
280
Phreesia
PHR
$756M
| $87.1M | 0.06% |
2,696,121
+19,242
| +0.7% | +$677K |
|
281
BlackLine
BL
$1.67B
| $86.1M | 0.06% |
1,281,913
-14,393
| -1% | -$992K |
|
282
Western Alliance Bancorporation
WAL
$8.98B
| $86M | 0.06% |
2,419,200
-3,639,043
| -60% | -$223M |
|
283
Markel Group
MKL
$22.7B
| $85.8M | 0.06% |
+67,165
| New | +$89.2M |
|
284
Mueller Water Products
MWA
$4.03B
| $85.7M | 0.06% |
6,150,927
+339,548
| +6% | +$4.42M |
|
285
US Physical Therapy
USPH
$1.23B
| $85.6M | 0.06% |
874,570
-41,261
| -5% | -$3.94M |
|
286
NeoGenomics
NEO
$2.11B
| $85.3M | 0.06% |
4,901,440
+1,984,505
| +68% | +$28.3M |
|
287
Dorman Products
DORM
$3.93B
| $85.1M | 0.06% |
986,389
+10,515
| +1% | +$936K |
|
288
Republic Services
RSG
$66B
| $84.9M | 0.06% |
+627,517
| New | +$80.1M |
|
289
Agilysys
AGYS
$3.04B
| $84.1M | 0.06% |
1,018,738
+89,265
| +10% | +$7.22M |
|
290
Caesars Entertainment
CZR
$6.07B
| $83.8M | 0.06% |
+1,717,030
| New | +$84.2M |
|
291
Virtus Investment Partners
VRTS
$1.12B
| $83.1M | 0.06% |
436,593
+3,211
| +0.7% | +$649K |
|
|
SRCL
292
DELISTED
Stericycle Inc
SRCL
| $82.6M | 0.06% |
1,893,735
-842,479
| -31% | -$41.7M |
|
|
BFS
293
Saul Centers
BFS
$857M
| $82.4M | 0.06% |
2,113,977
-1,647
| -0.1% | -$65.8K |
|
294
McGrath RentCorp
MGRC
$2.93B
| $82M | 0.06% |
878,505
+66,890
| +8% | +$6.61M |
|
295
Toast
TOST
$19.9B
| $81.8M | 0.06% |
4,607,591
-2,976,328
| -39% | -$58.7M |
|
296
Certara
CERT
$1.22B
| $79.7M | 0.06% |
3,304,129
+1,605,636
| +95% | +$31.7M |
|
297
Rivian
RIVN
$23.1B
| $78.6M | 0.06% |
5,079,742
-4,616,923
| -48% | -$78M |
|
|
XIFR
298
XPLR Infrastructure LP
XIFR
$1.09B
| $78.3M | 0.06% |
1,288,965
-502,301
| -28% | -$34.5M |
|
|
NEX
299
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $77.5M | 0.06% |
9,751,976
-469,862
| -5% | -$4.2M |
|
300
Procept Biorobotics
PRCT
$1.25B
| $77.4M | 0.06% |
2,725,289
+27,404
| +1% | +$967K |
|
Similar funds
T. Rowe Price Investment Management's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Investment Management held 578 positions worth $139B, up 7% from $130B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q1 2023 filing shows 37 new, 240 increased, 253 reduced and 34 closed positions. Its largest new stake was Intuit: 1,286,488 shares worth $574M. The largest sale was GE Aerospace, an estimated $1.2B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q1 2023 buy was Intuit: 1,286,488 shares worth $574M.
- T. Rowe Price Investment Management added most to UnitedHealth in Q1 2023, an estimated $883M increase.
- T. Rowe Price Investment Management's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $1.2B.
- T. Rowe Price Investment Management fully exited Public Service Enterprise Group in Q1 2023, selling an estimated $276M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $139B portfolio in Q1 2023.
- T. Rowe Price Investment Management opened 37 new positions and closed 34 in Q1 2023.
- T. Rowe Price Investment Management's portfolio value rose 7% quarter-over-quarter to $139B.
Based on T. Rowe Price Investment Management's 13F filing for Q1 2023, filed 15 May 2023.